Pfizer PFE is due to report third-quarter 2025 results on Nov. 4. All eyes will be on sales of Pfizer’s oncology drugs, which account for more than 25% of the company’s total revenues. Pfizer’s key ...

Pfizer's new COVID vaccine shows promising results with 4x immunity boost, but Kennedy's restrictions leave most Americans ...

Researchers found that among cancer patients getting immunotherapy, those who got an mRNA Covid vaccine within 100 days ...

Pfizer is backed by strong H1 results, a promising pipeline, improved financials, and solid valuation with long-term growth ...

Doses of the COVID-19 vaccine purchased through the federally funded Vaccines for Children program only started arriving this ...

Jeffrey Friedman, whose 1994 discovery of the hormone leptin changed how obesity is understood and treated, was awarded by ...

Key Points Sold entire holding of 109,630 shares; estimated trade value of approximately $2.66 million based on the quarterly average price Stake was previously 1.2% of fund AUM as of the prior ...

In August, the U.S. Food and Drug Administration approved the new COVID-19 booster shots, but with certain restrictions.

The mRNA therapeutics market offers key opportunities in developing vaccines and treatments for chronic and infectious diseases, driven by successful clinical trials and increased government and ...

Medical writing assistance was provided by Yolande Chalmers, EMJ, London, UK. The views and opinions expressed in this ...

After weeks of confusion, approval by CDC and its acting director mean most Nebraskans can get COVID-19 vaccines after ...

The market for VZV infection treatment is driven by increased vaccination and antiviral use, rising elderly populations, and strong immunization programs in developed regions. Key opportunities ...